About Rapid Medical
Rapid Medical is a company based in Yokneam Illit (Israel) founded in 2008. Rapid Medical has raised $79 million across 3 funding rounds from investors including MicroPort Orthopedics, CPE and Deep Insight. Rapid Medical offers products and services including Tigertriever, Tigertriever13, TigertrieverXL, Comaneci, and Columbus. Rapid Medical operates in a competitive market with competitors including Fluid Biomed, Cerus Endovascular, Oxford Endovascular, Anaconda Biomed and CoAxia, among others.
- Headquarter Yokneam Illit, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$79 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series D
May 06, 2021
-
Investors
MicroPort Orthopedics
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rapid Medical
Rapid Medical offers a comprehensive portfolio of products and services, including Tigertriever, Tigertriever13, TigertrieverXL, Comaneci, and Columbus.
Tool for precise control in ischemic stroke procedures.
Advanced device for targeted stroke intervention.
Enhanced tool for larger-scale stroke treatments.
Device for hemorrhagic stroke management and control.
Supportive device for neurovascular therapy applications.
People of Rapid Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Rapid Medical
Rapid Medical has successfully raised a total of $79M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rapid Medical
Rapid Medical has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include MicroPort Orthopedics, CPE and Deep Insight.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acquisitions are targeted by CPE as a private equity firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Private investment partnership focused on growth equity investments.
|
Locked | Locked | Locked |
Investor details for Rapid Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rapid Medical
Investment portfolio details for Rapid Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rapid Medical
Detailed financials for Rapid Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapid Medical Comparisons
Peer comparison for Rapid Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rapid Medical
Rapid Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fluid Biomed, Cerus Endovascular, Oxford Endovascular, Anaconda Biomed and CoAxia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Metallic mesh devices for brain aneurysms are developed.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
Detailed competitors of Rapid Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapid Medical
Complete news archive for Rapid Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rapid Medical
Rapid Medical was founded in 2008 and raised its 1st funding round 9 years after it was founded.
Rapid Medical is headquartered in Yokneam Illit, Israel. It is registered at Yokneam Illit, North District, Israel.
Rapid Medical is a funded company, having raised a total of $79M across 3 funding rounds to date.
Rapid Medical was founded in 2008 in Yokneam Illit, Israel, where neurovascular interventional devices are developed for medical applications. Products such as the Comaneci aneurysm neck-bridging device, Pele distal access catheter, and TigerTriever revascularization tool are included in the portfolio. Operations focus on devices that address acute ischemic strokes and related vascular blockages, with distribution centered in the medical device sector.
Rapid Medical's top competitors include Fluid Biomed, Anaconda Biomed and MicroVention.
Rapid Medical offers Tigertriever, Tigertriever13, TigertrieverXL, Comaneci, and Columbus.
Rapid Medical has 7 investors. Key investors include MicroPort Orthopedics, CPE, Deep Insight, JAM Capital Partners, and Agate Medical Investments.